NGNE
Neurogene Inc
25.90$
+1.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +338.6% | -41.2% | +4.1% | +11.5% | +5.9% | +9.2% | +6.6% | +4.8% | +8.6% | +1,407.5% | -94.1% | +27.2% | +1,161.7% | +12.5% | +5.0% | -93.2% | -1.0% | +1,893.3% | -5.8% | +15.7% | +9.0% | -11.0% | -95.4% | +8.5% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -15,178.7% | – | – | – | – | – | – | – | – | |
| – | +32.6% | -29.0% | +81.3% | -19.3% | +36.7% | -9.1% | +71.3% | -84.4% | -47.7% | -99.7% | +25.0% | +28,300.0% | +244.2% | +12.5% | -11.9% | +28.4% | +25.3% | +24.7% | +1.2% | +0.7% | -1.4% | +9.6% | +2.4% | -1.2% | -7.6% | +2.8% | +0.4% | +12.5% | +5.0% | +11.1% | +16.3% | +3.4% | -5.8% | +15.7% | +9.0% | -11.0% | +19.7% | +21.9% | +1.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -99.9% | +96,999.5% | -99.9% | +28.6% | +90,411.2% | +58.8% | -29.4% | +105.5% | +1.5% | +10.9% | +4.6% | +32.3% | -17.7% | -2.4% | +5.1% | +19.0% | +36.6% | – | |
| – | +38.4% | -25.7% | +64.2% | -13.8% | +37.0% | -9.2% | +49.9% | -70.2% | -35.8% | -45.1% | -5.6% | +420.6% | -28.8% | +7.8% | +1.3% | +6.8% | +26.4% | +18.5% | +1.0% | +1.9% | -2.1% | +1.1% | +3.1% | -85.6% | +525.4% | -10.2% | -81.4% | +58.8% | -29.4% | +604.4% | +12.7% | -70.9% | +4.6% | +32.3% | -17.7% | -2.4% | +307.8% | +21.5% | +12.8% | – | |
| – | – | – | – | – | – | – | – | -369.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.0% | +50.0% | +33.3% | -25.0% | +0.0% | +33.3% | -25.0% | -33.3% | +0.0% | -50.0% | +0.0% | +0.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | -613.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -810.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -2.5% | -229.1% | – | +340.1% | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -613.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -810.1% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -613.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -600.7% | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.